Felicia Gray

Felicia Gray is a Senior Principal Scientist at Schrödinger since April 2017, specializing in in vitro biology for drug discovery in oncology and nonhormonal contraception. Gray has extensive experience leading remote teams in generating data packages for early-stage drug discovery across various therapeutic areas, including immunology and neuroscience, and has served as a functional lead in target identification and evaluation. Prior roles include a Medical Writer at MedErgy HealthGroup, where research findings were translated into publications, and an Adjunct Lecturer at the University of Michigan, teaching critical analysis in Cancer Chemical Biology. Gray holds a PhD in Chemical Biology from the University of Michigan and a BA in Chemistry and Biology from Earlham College.